Gilead FY 2017 Hepatitis C Drug Sales Guidance Misses

CNBC
By Staff of CNBC
Business News Television Channel •

Gilead Q4 hepatitis C drug sales beat estimates.

(Video length 00:01:26)

Earnings are out for Gilead. CNBC's Meg Tirrell reports the details.​

STOCKS IN THIS ARTICLE

GILD
Track all markets on TradingView

More from this Author

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

CNBC •
Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

CNBC •
GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

CNBC •

Comments

Back to all articles